Receptor mediated uptake of a radiolabeled contrast agent sensitive to β-galactosidase activity
Authors:
- Angelique Y. LouieALAngelique Y. Louie
- Antranik ShahinianASAntranik Shahinian
- Thomas J. MeadeTMThomas J. Meade
- Peter S. ContiPCPeter S. Conti
- 1 April 2003
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 30 (3) , 261-265
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studiesProgress in Neurobiology, 2001
- In vivo visualization of gene expression using magnetic resonance imagingNature Biotechnology, 2000
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999
- Cellular Distribution of 111In-LDTPA Galactose BSA in Normal and Asialoglycoprotein Receptor-Deficient Mouse LiverNuclear Medicine and Biology, 1998
- A “Smart” Magnetic Resonance Imaging Agent That Reports on Specific Enzymatic ActivityAngewandte Chemie International Edition, 1997
- Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and RatsInvestigative Radiology, 1995
- Body Distribution of Galactose-Containing Synthetic Polymer and Galactosylated AlbuminPolymer Journal, 1993
- Fate of glycosylated dextrans after in vivo administrationJournal of Controlled Release, 1991
- Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and d-galactoseJournal of Cancer Research and Clinical Oncology, 1987
- TARGETING OF DRUGS: IMPLICATIONS IN MEDICINEThe Lancet, 1981